Skip to main content
Caplight Logo









ResQ Biotech

ResQ Biotech

Private
GreeceHealthcare & Life Scienceshttps://resqbiotech.com/

Last Round

Seed

Dec 5, 2023

Total Funding Raised

$1.1M

Company Overview

ResQ Biotech is a biotechnology company that develops platform technology for drug discovery targeting diseases caused by protein misfolding and aggregation.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

drug discoverysynthetic biologytechbiocyclic oligopeptidesprotein misfoldingdiscovery-as-a-servicetherapeutic lead generationhigh-throughput screeningpeptide therapeuticsneurodegenerative diseasebiotech R&Ddrug pipelinepreclinical researchprotein engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ResQ Biotech Comparables

Compare ResQ Biotech with similar companies based on industry and business-model similarity.

ResQ Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ND Biosciences
84%
20n Bio
82%
Insamo
81%

ResQ Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 5, 2023

ResQ Biotech Investors

Notable investors and investment history

ResQ Biotech investors
InvestorRounds
Blue Dome CapitalSeed
egg - enter•grow•goSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 5, 2023

    $1.1M round with Blue Dome Capital and egg - enter•grow•go

ResQ Biotech Filings

Explore SEC and related filing metadata, where available.

ResQ Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ResQ Biotech's valuation, stock price, and market status.

Is ResQ Biotech a public or private company?

ResQ Biotech is a private company.

What is the current stock price of ResQ Biotech?

ResQ Biotech is a private company with no public stock price. Caplight tracks ResQ Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is ResQ Biotech worth (valuation)?

Valuation information for ResQ Biotech is not publicly available.

Can I buy ResQ Biotech stock?

ResQ Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ResQ Biotech's last funding round?

ResQ Biotech's most recent funding round was Seed on December 5, 2023.

Who are the main investors in ResQ Biotech?

Key investors in ResQ Biotech include Blue Dome Capital, egg - enter•grow•go.

Will ResQ Biotech IPO soon?

No public IPO plans have been announced for ResQ Biotech.

How can I track ResQ Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ResQ Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGreece
Employee Range6
Year Founded2019
Last FundingDec 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?